TipRanks
Alterity Therapeutics (PRNAF)
OTHER OTC:PRNAF
US Market
PRNAF
Alterity Therapeutics
RESEARCH TOOLSreports

Alterity Therapeutics (PRNAF) Income Statement

7 Followers

Alterity Therapeutics Income Statement

Last quarter (Q4 2026), Alterity Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Alterity Therapeutics's net income was AU$-13.79M. See Alterity Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 0.00AU$ 5.44MAU$ 4.02MAU$ 3.92MAU$ 5.12M
Gross Profit
AU$ -115.54KAU$ 5.31MAU$ 3.80MAU$ 3.63MAU$ 4.76M
Operating Expenses
AU$ 28.30MAU$ 19.89MAU$ 23.41MAU$ 18.24MAU$ 20.26M
Depreciation and Amortization
AU$ 115.54KAU$ 28.31KAU$ 147.53KAU$ 102.26KAU$ 54.21K
EBITDA
AU$ -28.30MAU$ -14.63MAU$ -19.46MAU$ -17.51MAU$ -17.39M
Operating Income
AU$ -28.42MAU$ -14.57MAU$ -19.60MAU$ -14.64MAU$ -15.50M
Other Income/Expenses
AU$ 1.52MAU$ 2.49MAU$ 524.33KAU$ 904.68KAU$ 2.72M
Pretax Income
AU$ -26.90MAU$ -12.08MAU$ -19.08MAU$ -13.70MAU$ -12.78M
Net Income
AU$ -23.40MAU$ -12.15MAU$ -19.12MAU$ -13.81MAU$ -12.85M
Per Share Metrics
Basic EPS
AU$ -0.11AU$ -0.10AU$ -0.26AU$ -0.28AU$ -0.27
Diluted EPS
AU$ -0.11AU$ -0.10AU$ -0.26AU$ -0.28AU$ -0.27
Weighted Average Shares Outstanding
 210.49M 127.94M 72.98M 48.56M 48.12M
Weighted Average Shares Outstanding (Diluted)
 210.49M 127.94M 72.98M 48.56M 48.12M
Currency in AUD

Alterity Therapeutics Earnings and Revenue History